Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics

por Arlett, Peter, Straus, Sabine, Rasi, Guido
Publicado 2019

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines

por Cavaleri, Marco, Enzmann, Harald, Straus, Sabine, Cooke, Emer
Publicado 2021

Improving the Safety of Medicines in the European Union: From Signals to Action

por Potts, Joanne, Genov, Georgy, Segec, Andrej, Raine, June, Straus, Sabine, Arlett, Peter
Publicado 2019

Patient Preferences for Rituximab Additional Risk Minimization Measures: Results From an International Online Survey

por Schneiderova, Kristyna, Bere, Nathalie, Stenver, Doris Irene, Straus, Sabine M. J. M.
Publicado 2022

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation

por Vatzaki, Efstratia, Straus, Sabine, Dogne, Jean-Michel, Garcia Burgos, Juan, Girard, Thomas, Martelletti, Paolo
Publicado 2018

Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use

por Santoro, Aniello, Caplanusi, Irina, Sweeney, Fergus, Cappelli, Benedicte, Nolan, Lorraine, Straus, Sabine, Arlett, Peter
Publicado 2020

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Sta...

por Bahri, Priya, Morales, Daniel R., Inoubli, Adrien, Dogné, Jean-Michel, Straus, Sabine M. J. M.
Publicado 2020

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

por Mazzaglia, Giampiero, Straus, Sabine M. J., Arlett, Peter, da Silva, Daniela, Janssen, Heidi, Raine, June, Alteri, Enrica
Publicado 2017

Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021

por Essink, Sharon C. M., Zomerdijk, Inge M., Straus, Sabine M. J. M., Gardarsdottir, Helga, De Bruin, Marie L.
Publicado 2023

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase

por Willemen, Marjolein J., Mantel-Teeuwisse, Aukje K., Straus, Sabine M., Meyboom, Ron H., Egberts, Toine C., Leufkens, Hubert G.
Publicado 2011

Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union

por Hoeve, Christina E., Francisca, Reynold D. C., Zomerdijk, Inge, Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Publicado 2019

Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors

por Hoeve, Christina E., de Vries, Esther, Mol, Peter G. M., Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Publicado 2020

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis

por Duijnhoven, Ruben G., Straus, Sabine M. J. M., Raine, June M., de Boer, Anthonius, Hoes, Arno W., De Bruin, Marie L.
Publicado 2013

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012

por Gadroen, Kartini, Kemmeren, Jeanet M, Bruijning-Verhagen, Patricia CJ, Straus, Sabine MJM, Weibel, Daniel, de Melker, Hester E, Sturkenboom, Miriam CJM
Publicado 2017

Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe

por Francisca, Reynold D. C., Baba, Emna, Hoeve, Christina E., Zomerdijk, Inge M., Sturkenboom, Miriam C. J. M., Straus, Sabine M. J. M.
Publicado 2020

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project

por de Bie, Sandra, Ferrajolo, Carmen, Straus, Sabine M. J. M., Verhamme, Katia M. C., Bonhoeffer, Jan, Wong, Ian C. K., Sturkenboom, Miriam C. J. M.
Publicado 2015

Isotretinoin exposure during pregnancy: a population-based study in The Netherlands

por Zomerdijk, Ingeborg M, Ruiter, Rikje, Houweling, Leanne M A, Herings, Ron M C, Sturkenboom, Miriam C J M, Straus, Sabine M J M, Stricker, Bruno H
Publicado 2014

Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action

por Radecka, Anna, Loughlin, Louise, Foy, Mick, de Ferraz Guimaraes, Margarida Viana, Sarinic, Viola Macolic, Di Giusti, Marina Dimov, Lesicar, Marina, Straus, Sabine, Montero, Dolores, Pallos, Julia, Ivanovic, Jelena, Raine, June
Publicado 2018

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study

por Ruiter, Rikje, Visser, Loes E., van Herk-Sukel, Myrthe P.P., Coebergh, Jan-Willem W., Haak, Harm R., Geelhoed-Duijvestijn, Petronella H., Straus, Sabine M.J.M., Herings, Ron M.C., Stricker, Bruno H.Ch.
Publicado 2012

Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection

por Pacurariu, Alexandra C., Straus, Sabine M., Trifirò, Gianluca, Schuemie, Martijn J., Gini, Rosa, Herings, Ron, Mazzaglia, Giampiero, Picelli, Gino, Scotti, Lorenza, Pedersen, Lars, Arlett, Peter, van der Lei, Johan, Sturkenboom, Miriam C., Coloma, Preciosa M.
Publicado 2015